Outcomes of natalizumab treatment within 3 years of...

BMC Neurology 2019 / 12 Vol. 19; Iss. 1

Outcomes of natalizumab treatment within 3 years of relapsing-remitting multiple sclerosis diagnosis: a prespecified 2-year interim analysis of STRIVE

Perumal, Jai, Fox, Robert J., Balabanov, Roumen, Balcer, Laura J., Galetta, Steven, Makh, Shavy, Santra, Sourav, Hotermans, Christophe, Lee, Lily
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
19
Journal:
BMC Neurology
DOI:
10.1186/s12883-019-1337-z
Date:
December, 2019
File:
PDF, 1024 KB
2019
Conversion to is in progress
Conversion to is failed